These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 2888164)
41. [Current viewpoints in the pathogenesis of Kawasaki disease]. Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390 [No Abstract] [Full Text] [Related]
42. [Diagnostic and therapeutic standards for rheumatic diseases in children]. Prusek W Pol Merkur Lekarski; 2002 Feb; 12(68):152-6. PubMed ID: 11995255 [TBL] [Abstract][Full Text] [Related]
46. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center]. Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328 [TBL] [Abstract][Full Text] [Related]
50. [Kawasaki disease complicated by thrombosis of the internal carotid artery]. Lauret P; Lecointre C; Billard JL Ann Dermatol Venereol; 1979 Nov; 106(11):901-5. PubMed ID: 44165 [No Abstract] [Full Text] [Related]
51. [Kawasaki disease: recent findings in etiology, pathogenesis and therapy]. Di Piero G; Bellisario G; Di Maggio M; Garibaldi G; Isola ML; Pauselli F; Proia R Pediatr Med Chir; 1989; 11(2):209-17. PubMed ID: 2668907 [TBL] [Abstract][Full Text] [Related]
52. Immune complex study of biopsy specimens from Kawasaki disease patients. Fujimoto T; Kato H; Inoue O; Tomita S; Koga Y Prog Clin Biol Res; 1987; 250():209-17. PubMed ID: 3321077 [No Abstract] [Full Text] [Related]
54. New developments in Kawasaki disease. Leung DY Curr Opin Rheumatol; 1991 Feb; 3(1):46-55. PubMed ID: 1710476 [TBL] [Abstract][Full Text] [Related]
55. Clinical features of patients with Kawasaki disease whose parents had the same disease. Uehara R; Yashiro M; Nakamura Y; Yanagawa H Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1166-9. PubMed ID: 15583102 [TBL] [Abstract][Full Text] [Related]
56. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease. Iwasa M; Sugiyama K; Ando T; Nomura H; Katoh T; Wada Y Prog Clin Biol Res; 1987; 250():543-4. PubMed ID: 3423068 [No Abstract] [Full Text] [Related]
57. Juvenile polyarteritis nodosa associated with toxoplasmosis presenting as Kawasaki disease. Başaran Ö; Çakar N; Gür G; Kocabaş A; Gülhan B; Çaycı FŞ; Çelikel BA Pediatr Int; 2014 Apr; 56(2):262-4. PubMed ID: 24730628 [TBL] [Abstract][Full Text] [Related]
58. Kawasaki disease: who is at risk? Newburger JW J Pediatr; 2000 Aug; 137(2):149-52. PubMed ID: 10931403 [No Abstract] [Full Text] [Related]
59. [Clinical and therapeutic aspects of Kawasaki disease. Clinical contribution]. Massimo L; Di Luna F; Sottile R; Fidelini N; Alvano L; De Vita L Pediatr Med Chir; 1987; 9(5):613-8. PubMed ID: 3441437 [TBL] [Abstract][Full Text] [Related]
60. [Exchange transfusion in a case of Kawasaki syndrome]. Netter JC; Fries F; Rajon AM; Carrière JP; Dalous A Arch Fr Pediatr; 1982 Nov; 39(9):699-701. PubMed ID: 7165465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]